Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study.

N Caspi1, I Modai, P Barak

  • 1Sha'ar Menashe Mental Health Center and Institute of Psychiatric Studies, Haifa, Israel.

International Clinical Psychopharmacology
|March 10, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adapting to the digital age in psychiatry: evaluating change in emergency department nurses and psychiatrists' views toward telepsychiatry for involuntary hospitalization.

Frontiers in digital health·2026
Same author

Safety and efficacy of intravenous cyclophosphamide pulse therapy in therapy refractory Crohn's disease patients.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2017
Same author

The Rubber Hand Illusion paradigm as a sensory learning process in patients with schizophrenia.

European psychiatry : the journal of the Association of European Psychiatrists·2015
Same author

Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia.

Neuroreport·2004
Same author

Is the WKL1 gene associated with schizophrenia?

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2004
Same author

Quality of life and coping with schizophrenia symptoms.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2003

Augmenting antipsychotic treatment with pindolol significantly reduced aggressive incidents and their severity in schizophrenic patients. This suggests pindolol is an effective adjunctive therapy for managing aggression in schizophrenia.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Aggression in schizophrenic patients presents a significant clinical challenge.
  • Existing antipsychotic treatments may require augmentation for optimal efficacy.

Purpose of the Study:

  • To investigate the efficacy of adding pindolol to antipsychotic treatment for reducing aggression in schizophrenia.
  • To evaluate the impact of pindolol on both the frequency and severity of aggressive incidents.

Main Methods:

  • A double-blind, crossover study involving 30 male inpatients diagnosed with schizophrenia.
  • Patients received either pindolol or placebo as augmentation therapy, with aggression assessed using the Overt Aggression Scale (OAS).
  • The Positive and Negative Syndrome Scale (PANSS) was used to monitor overall symptomology.

Related Experiment Videos

Main Results:

  • Pindolol augmentation significantly decreased the number of aggressive incidents towards objects and persons compared to placebo.
  • The severity of aggressive incidents was also significantly reduced with pindolol treatment.
  • No significant differences in PANSS scores were observed between pindolol and placebo groups, indicating a specific effect on aggression.

Conclusions:

  • Pindolol, through its combined beta and 5-HT1A blocking effects, effectively ameliorates both the number and severity of aggressive acts in schizophrenic patients.
  • The reduction in aggression severity may be linked to pindolol's 5-HT1A antagonistic properties.